We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$4.3B
AUM Growth
+$519M
Cap. Flow
-$26.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
43.48%
Holding
487
New
10
Increased
143
Reduced
81
Closed
22
Avg Time Held
20.8 quarters
Top 10 Avg Time Held
24 quarters
Top 20 Avg Time Held
16.2 quarters

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$38.6M
2
SYK icon
Stryker
SYK
+$37.7M
3
COF icon
Capital One
COF
+$33.6M
4
DOV icon
Dover
DOV
+$31M
5
RDNT icon
RadNet
RDNT
+$23.4M

Top Sells

Rank Stock Value
1
CBOE icon
Cboe Global Markets
CBOE
+$56.7M
2
GILD icon
Gilead Sciences
GILD
+$44.4M
3
T icon
AT&T
T
+$34.8M
4
INTU icon
Intuit
INTU
+$32.5M
5
BSX icon
Boston Scientific
BSX
+$29.4M

Sector Composition

Rank Sector Weight
1 Technology 43.83%
2 Financials 13.15%
3 Healthcare 10.01%
4 Communication Services 9.79%
5 Consumer Discretionary 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LOW icon
101
Lowe's Companies
LOW
$106B
$4.86M 0.11%
22,027
– –
2013 Q2
52 quarters
PFE icon
102
Pfizer
PFE
$162B
$4.79M 0.11%
199,117
– –
2025 Q4
2 quarters
CDNS icon
103
Cadence Design Systems
CDNS
$92B
$4.72M 0.11%
12,576
+450
+4% +$158K
2016 Q2
40 quarters
TJX icon
104
TJX Companies
TJX
$156B
$4.65M 0.11%
30,680
-13,050
-30% -$2.06M
2013 Q2
52 quarters
DELL icon
105
Dell
DELL
$364B
$4.44M 0.1%
10,300
-500
-5% -$145K
2025 Q4
2 quarters
VRTX icon
106
Vertex Pharmaceuticals
VRTX
$123B
$4.38M 0.1%
8,823
– –
2023 Q3
11 quarters
APP icon
107
Applovin
APP
$91.1B
$4.3M 0.1%
8,341
+2,750
+49% +$1.33M
2025 Q4
2 quarters
DHR icon
108
Danaher
DHR
$157B
$4.24M 0.1%
22,273
– –
2021 Q2
20 quarters
DNLI icon
109
Denali Therapeutics
DNLI
$2.94B
$4.12M 0.1%
+160,000
New +$3.29M
2026 Q2
0 quarters
LNTH icon
110
Lantheus
LNTH
$6.53B
$4.1M 0.1%
36,937
– –
2020 Q3
23 quarters
CRUS icon
111
Cirrus Logic
CRUS
$5.41B
$4.09M 0.1%
27,553
+1,341
+5% +$219K
2019 Q4
26 quarters
SPGI icon
112
S&P Global
SPGI
$121B
$4.04M 0.09%
10,476
-3,300
-24% -$1.39M
2016 Q2
40 quarters
LOB icon
113
Live Oak Bancshares
LOB
$1.61B
$4.03M 0.09%
98,745
– –
2024 Q1
9 quarters
BMY icon
114
Bristol-Myers Squibb
BMY
$116B
$4.01M 0.09%
69,612
– –
2023 Q4
10 quarters
RGEN icon
115
Repligen
RGEN
$11.1B
$3.9M 0.09%
28,600
– –
2025 Q4
2 quarters
CMCSA icon
116
Comcast
CMCSA
$74.1B
$3.86M 0.09%
157,351
+3,000
+2% +$77.4K
2013 Q2
52 quarters
SCHW icon
117
Charles Schwab
SCHW
$166B
$3.85M 0.09%
41,700
+2,000
+5% +$182K
2025 Q4
2 quarters
HWM icon
118
Howmet Aerospace
HWM
$86.5B
$3.8M 0.09%
14,152
+1,500
+12% +$385K
2025 Q4
2 quarters
OCUL icon
119
Ocular Therapeutix
OCUL
$1.59B
$3.78M 0.09%
385,000
+85,000
+28% +$770K
2026 Q1
1 quarter
CAVA icon
120
CAVA Group
CAVA
$6.19B
$3.72M 0.09%
47,370
+6,281
+15% +$527K
2026 Q1
1 quarter
FUTU icon
121
Futu Holdings
FUTU
$16B
$3.69M 0.09%
39,400
+36,000
+1,059% +$4.61M
2025 Q4
2 quarters
SBUX icon
122
Starbucks
SBUX
$105B
$3.69M 0.09%
36,114
+5,400
+18% +$544K
2013 Q2
52 quarters
VERA icon
123
Vera Therapeutics
VERA
$1.93B
$3.68M 0.09%
85,777
+42,787
+100% +$1.59M
2025 Q4
2 quarters
PWR icon
124
Quanta Services
PWR
$104B
$3.65M 0.08%
5,070
– –
2022 Q2
16 quarters
IBP icon
125
Installed Building Products
IBP
$5B
$3.61M 0.08%
15,711
+3,365
+27% +$818K
2021 Q2
20 quarters
3 4
5
6 7

Similar funds

AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.3B AUM 24.01% 1-Year Est. Return
GHC
Great Hill Capital New York $4.29B AUM 18.17% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $4.28B AUM 19.27% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $4.28B AUM 80.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $4.28B AUM 43.07% 1-Year Est. Return

E. Ohman J:or Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, E. Ohman J:or Asset Management held 487 positions worth $4.3B, up 14% from $3.78B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

E. Ohman J:or Asset Management's Q2 2026 filing shows 10 new, 143 increased, 81 reduced and 22 closed positions. Its largest new stake was Denali Therapeutics: 160,000 shares worth $4.12M. The largest sale was Cboe Global Markets, an estimated $56.7M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.

  • E. Ohman J:or Asset Management's largest Q2 2026 buy was Denali Therapeutics: 160,000 shares worth $4.12M.
  • E. Ohman J:or Asset Management added most to Eli Lilly in Q2 2026, an estimated $38.6M increase.
  • E. Ohman J:or Asset Management's biggest Q2 2026 reduction was Cboe Global Markets, cutting an estimated $56.7M.
  • E. Ohman J:or Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $1.17M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 43% of its $4.3B portfolio in Q2 2026.
  • E. Ohman J:or Asset Management opened 10 new positions and closed 22 in Q2 2026.
  • E. Ohman J:or Asset Management's portfolio value rose 14% quarter-over-quarter to $4.3B.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.